JP2023501924A - 折り畳まれた遠位端を有する吸入器物品 - Google Patents
折り畳まれた遠位端を有する吸入器物品 Download PDFInfo
- Publication number
- JP2023501924A JP2023501924A JP2022524037A JP2022524037A JP2023501924A JP 2023501924 A JP2023501924 A JP 2023501924A JP 2022524037 A JP2022524037 A JP 2022524037A JP 2022524037 A JP2022524037 A JP 2022524037A JP 2023501924 A JP2023501924 A JP 2023501924A
- Authority
- JP
- Japan
- Prior art keywords
- sleeve
- inhaler article
- inhaler
- cavity
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 claims abstract description 212
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 34
- 239000002245 particle Substances 0.000 claims description 133
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 90
- 229960002715 nicotine Drugs 0.000 description 84
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 84
- 239000000843 powder Substances 0.000 description 48
- 239000000796 flavoring agent Substances 0.000 description 37
- 235000019634 flavors Nutrition 0.000 description 36
- 230000000149 penetrating effect Effects 0.000 description 36
- 239000000463 material Substances 0.000 description 26
- 210000004072 lung Anatomy 0.000 description 15
- 230000000391 smoking effect Effects 0.000 description 13
- 238000000034 method Methods 0.000 description 11
- 239000000123 paper Substances 0.000 description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 230000004888 barrier function Effects 0.000 description 6
- 235000019504 cigarettes Nutrition 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- -1 salt hydrates Chemical class 0.000 description 6
- 229960003136 leucine Drugs 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 239000004395 L-leucine Substances 0.000 description 4
- 235000019454 L-leucine Nutrition 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- MMOPGICOOYBFJU-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;2-oxopropanoic acid Chemical compound CC(=O)C(O)=O.CN1CCCC1C1=CC=CN=C1 MMOPGICOOYBFJU-UHFFFAOYSA-N 0.000 description 2
- FFYVQVZXWDGRAY-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;hydrate Chemical class O.CN1CCCC1C1=CC=CN=C1 FFYVQVZXWDGRAY-UHFFFAOYSA-N 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 230000003434 inspiratory effect Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- LDMPZNTVIGIREC-ZGPNLCEMSA-N nicotine bitartrate Chemical compound O.O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 LDMPZNTVIGIREC-ZGPNLCEMSA-N 0.000 description 2
- 229940069688 nicotine bitartrate Drugs 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- GKTOAHZEMRRUKF-HVDRVSQOSA-N (2s)-2-aminopentanedioic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound OC(=O)[C@@H](N)CCC(O)=O.CN1CCCC1C1=CC=CN=C1 GKTOAHZEMRRUKF-HVDRVSQOSA-N 0.000 description 1
- SKZDZXPBBYUFBY-WLHGVMLRSA-N (e)-but-2-enedioic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound OC(=O)\C=C\C(O)=O.CN1CCCC1C1=CC=CN=C1 SKZDZXPBBYUFBY-WLHGVMLRSA-N 0.000 description 1
- AIBWPBUAKCMKNS-PPHPATTJSA-N 2-hydroxybenzoic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)C1=CC=CC=C1O.CN1CCC[C@H]1C1=CC=CN=C1 AIBWPBUAKCMKNS-PPHPATTJSA-N 0.000 description 1
- SDVKWBNZJFWIMO-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CN1CCCC1C1=CC=CN=C1.OC(=O)CC(O)(C(O)=O)CC(O)=O SDVKWBNZJFWIMO-UHFFFAOYSA-N 0.000 description 1
- VWTHFJXLFGINSW-PPHPATTJSA-N 2-hydroxypropanoic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound CC(O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 VWTHFJXLFGINSW-PPHPATTJSA-N 0.000 description 1
- HDJBTCAJIMNXEW-PPHPATTJSA-N 3-[(2s)-1-methylpyrrolidin-2-yl]pyridine;hydrochloride Chemical compound Cl.CN1CCC[C@H]1C1=CC=CN=C1 HDJBTCAJIMNXEW-PPHPATTJSA-N 0.000 description 1
- 229910000619 316 stainless steel Inorganic materials 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920000106 Liquid crystal polymer Polymers 0.000 description 1
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000011246 composite particle Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000005489 elastic deformation Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 239000003571 electronic cigarette Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005243 fluidization Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000001339 gustatory effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- ORQBXQOJMQIAOY-UHFFFAOYSA-N nobelium Chemical compound [No] ORQBXQOJMQIAOY-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- SCUZVMOVTVSBLE-UHFFFAOYSA-N prop-2-enenitrile;styrene Chemical compound C=CC#N.C=CC1=CC=CC=C1 SCUZVMOVTVSBLE-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229920000638 styrene acrylonitrile Polymers 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
- A61M11/003—Particle size control by passing the aerosol trough sieves or filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
- A24F42/20—Devices without heating means
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
- A24F42/60—Constructional details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/002—Details of inhalators; Constructional features thereof with air flow regulating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0035—Piercing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/004—Details of the piercing or cutting means with fixed piercing or cutting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/75—General characteristics of the apparatus with filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Cigarettes, Filters, And Manufacturing Of Filters (AREA)
Abstract
Description
Claims (17)
- 吸入器物品であって、
長軸方向軸に沿って、マウスピース端から遠位端に延びる本体と、
前記本体内に画定され、フィルター要素によって下流で境界を接し、かつ変形可能要素によって上流および遠位で境界を接するカプセル空洞であって、前記変形可能要素が変形して、開放遠位端を露出し、消費中に前記吸入器物品が渦巻または回転吸入気流を受けることを可能にする、カプセル空洞と、
前記カプセル空洞の中に配置されるカプセルと、を含む、吸入器物品。 - 前記変形可能要素が、前記本体の前記遠位端で折り畳まれる、請求項1に記載の吸入器物品。
- 前記変形可能要素が、前記本体の前記遠位端で扇状に折り畳まれる、請求項2に記載の吸入器物品。
- 前記変形可能要素の折り畳まれたセクションが、それ自体に折り畳まれて開放開口部を画定し、渦巻または回転する吸入気流を受ける、請求項1に記載の吸入器物品。
- 前記カプセル空洞の前記上流境界が、前記吸入器物品の閉鎖端を形成する前記変形可能要素により画定される、請求項1~4のいずれかに記載の吸入器物品。
- 前記カプセル空洞の前記上流境界が、前記吸入器物品の開放端を形成する前記変形可能要素により画定される、請求項1~5のいずれかに記載の吸入器物品。
- 前記変形可能要素の少なくとも一部が紙で形成される、請求項1~6のいずれかに記載の吸入器物品。
- 前記変形可能要素が、前記カプセル空洞の長軸方向の側壁の少なくとも一部分を画定する、請求項1~7のいずれかに記載の吸入器物品。
- 前記変形可能要素が、前記カプセル空洞の大部分を画定する、請求項1~8のいずれかに記載の吸入器物品。
- 前記フィルター要素および前記変形可能要素を囲むラッピング層をさらに含む、請求項1~9のいずれかに記載の吸入器物品。
- 前記ラッピング層が、前記フィルター要素と前記変形可能要素を結合する、請求項10に記載の吸入器物品。
- 前記変形可能要素が前記ラッピング層を超えて延びる、請求項10あるいは請求項11に記載の吸入器物品。
- 前記変形可能要素が、約0.5mm~約5mm、または約1mm~約4mm、または約2mm~約3mmの範囲の前記ラッピング層を超えて延びる、請求項12に記載の吸入器物品。
- 前記カプセルが医薬的に活性な粒子を含む、請求項1~13のいずれかに記載の吸入器。
- 吸入器システムであって、
請求項1~14のいずれかに記載の吸入器物品と、
吸入器物品向けのホルダーであって、渦巻または回転吸入気流を前記吸入器物品に提供するように構成されたホルダーと、を含む、吸入器システム。 - 前記ホルダーが、前記ハウジング空洞内に前記吸入器物品を保持するように構成されたスリーブを備え、前記スリーブが、スリーブ空洞を備え、前記ハウジングの長軸方向軸に沿って前記ハウジング空洞内で移動可能であり、前記スリーブが、第一の開放端および第二の対向端を備え、前記スリーブの前記第二の対向端が、空気が前記スリーブ空洞に入ることを可能にするように構成され、
前記スリーブの前記第二の対向端が、前記スリーブ空洞内に延在するスリーブ管状要素を備え、前記スリーブ管状要素が、前記吸入器物品の前記変形可能要素を貫通し、前記スリーブ内に前記吸入器物品を固定するように構成される、請求項15に記載の吸入器システム。 - 前記スリーブ管状要素が、前記カプセル空洞の前記上流境界を形成する、請求項16に記載の吸入器システム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19205453.4 | 2019-10-25 | ||
EP19205453 | 2019-10-25 | ||
PCT/IB2020/059990 WO2021079341A1 (en) | 2019-10-25 | 2020-10-23 | Inhaler article with folded distal end |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2023501924A true JP2023501924A (ja) | 2023-01-20 |
JPWO2021079341A5 JPWO2021079341A5 (ja) | 2023-10-11 |
JP7480287B2 JP7480287B2 (ja) | 2024-05-09 |
Family
ID=68382195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022524037A Active JP7480287B2 (ja) | 2019-10-25 | 2020-10-23 | 折り畳まれた遠位端を有する吸入器物品 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220387737A1 (ja) |
EP (1) | EP4048353B1 (ja) |
JP (1) | JP7480287B2 (ja) |
KR (1) | KR20220087438A (ja) |
CN (1) | CN114555161A (ja) |
AU (1) | AU2020372031A1 (ja) |
BR (1) | BR112022005385A2 (ja) |
CA (1) | CA3149765A1 (ja) |
IL (1) | IL292279A (ja) |
MX (1) | MX2022004880A (ja) |
WO (1) | WO2021079341A1 (ja) |
ZA (1) | ZA202201976B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117479848A (zh) * | 2021-08-06 | 2024-01-30 | 菲利普莫里斯生产公司 | 其折叠端部具有一致外观的吸入器制品 |
EP4311566A1 (en) * | 2022-07-28 | 2024-01-31 | Vectura Inc. | An inhaler comprising a retention element |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201811250TA (en) * | 2016-07-07 | 2019-01-30 | Philip Morris Products Sa | Nicotine inhaler system |
EP3548126B1 (en) | 2016-11-30 | 2021-07-14 | Philip Morris Products S.A. | Inhaler with sized cavity |
CN111163651A (zh) | 2017-10-25 | 2020-05-15 | 菲利普莫里斯生产公司 | 具有边界元件的吸入器 |
CN114642275A (zh) * | 2017-10-25 | 2022-06-21 | 菲利普莫里斯生产公司 | 用于吸入器制品和系统的刺穿附件 |
WO2019123297A1 (en) * | 2017-12-22 | 2019-06-27 | G.D S.P.A. | Sub-unit of a smoking article and method for making it |
CN111801026B (zh) * | 2018-03-26 | 2024-04-19 | 菲利普莫里斯生产公司 | 具有有孔的多孔支撑元件的吸入器 |
EP3772258B1 (en) | 2018-03-26 | 2023-10-25 | Philip Morris Products S.A. | Inhaler with vortex capsule cavity |
WO2019186395A1 (en) | 2018-03-26 | 2019-10-03 | Philip Morris Products S.A. | Inhaler with composite porous support element |
-
2020
- 2020-10-23 BR BR112022005385A patent/BR112022005385A2/pt unknown
- 2020-10-23 CN CN202080070474.7A patent/CN114555161A/zh active Pending
- 2020-10-23 MX MX2022004880A patent/MX2022004880A/es unknown
- 2020-10-23 AU AU2020372031A patent/AU2020372031A1/en active Pending
- 2020-10-23 US US17/770,730 patent/US20220387737A1/en active Pending
- 2020-10-23 EP EP20797201.9A patent/EP4048353B1/en active Active
- 2020-10-23 WO PCT/IB2020/059990 patent/WO2021079341A1/en active Search and Examination
- 2020-10-23 CA CA3149765A patent/CA3149765A1/en active Pending
- 2020-10-23 KR KR1020227011209A patent/KR20220087438A/ko unknown
- 2020-10-23 JP JP2022524037A patent/JP7480287B2/ja active Active
-
2022
- 2022-02-16 ZA ZA2022/01976A patent/ZA202201976B/en unknown
- 2022-04-14 IL IL292279A patent/IL292279A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20220387737A1 (en) | 2022-12-08 |
AU2020372031A1 (en) | 2022-03-03 |
BR112022005385A2 (pt) | 2022-06-21 |
WO2021079341A1 (en) | 2021-04-29 |
KR20220087438A (ko) | 2022-06-24 |
ZA202201976B (en) | 2023-12-20 |
EP4048353B1 (en) | 2024-06-19 |
CN114555161A (zh) | 2022-05-27 |
JP7480287B2 (ja) | 2024-05-09 |
CA3149765A1 (en) | 2021-04-29 |
IL292279A (en) | 2022-06-01 |
MX2022004880A (es) | 2022-05-16 |
EP4048353A1 (en) | 2022-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3934721B1 (en) | Piercing device for inhaler article | |
EP3934720B1 (en) | Holder for inhaler article | |
JP7480287B2 (ja) | 折り畳まれた遠位端を有する吸入器物品 | |
EP4048105B1 (en) | Inhaler article with open distal end, and inhaler system | |
JP2023534514A (ja) | 吸入器物品 | |
EP4048354B1 (en) | Inhaler article with tangential airflow end element | |
EP4048355B1 (en) | Holder for inhaler article | |
JP7504993B2 (ja) | 二重起動の防止 | |
RU2798557C2 (ru) | Держатель для изделия в виде ингалятора | |
EP4054683B1 (en) | Double activation prevention | |
JPWO2020178715A5 (ja) | ||
KR20230146570A (ko) | 이중 활성화 방지 홀더 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230928 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230928 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240319 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240325 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240424 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7480287 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |